$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

류마티스 관절염에서 NLRP3 인플라마좀의 역할
Role of NLRP3 Inflammasome in Rheumatoid Arthritis 원문보기

대한융합한의학회지 = Journal of Convergence Korean Medicine, v.4 no.1, 2022년, pp.5 - 11  

김현진 (우석대학교) ,  정수현 (우석대학교) ,  이준호 (우석대학교) ,  김대용 (우석대학교) ,  양갑식 (우석대학교)

Abstract AI-Helper 아이콘AI-Helper

Objectives: Inflammasomes are molecular platforms that are generated inside cytoplasmic compartments. The objective is to mediate immunological responses of the host to cell damage and infection. Caspase-1 is triggered by inflammasome to generate interleukin-1𝛽 (IL-1𝛽), an inflammato...

주제어

표/그림 (1)

참고문헌 (46)

  1. McInnes IB, Schett G. The pathogenesis of?rheumatoid arthritis. N Engl J Med.?2011;365(23):2205-19. 

  2. George G, Shyni GL, Raghu KG. Current and?novel therapeutic targets in the treatment of?rheumatoid arthritis. Inflammopharmacology.?2020;28(6):1457-76. 

  3. Cheng L, Liang X, Qian L, Luo C, Li D.?NLRP3 gene polymorphisms and expression in?rheumatoid arthritis. Exp Ther Med.?2021;22(4):1110. 

  4. Crowson CS, Matteson EL, Myasoedova E,?Michet CJ, Ernste FC, Warrington KJ, et al.?The lifetime risk of adult-onset rheumatoid?arthritis and other inflammatory autoimmune?rheumatic diseases. Arthritis Rheum. 2011;63(3):633-9. 

  5. Safiri S, Kolahi AA, Hoy D, Smith E,?Bettampadi D, Mansournia MA, et al. Global,?regional and national burden of rheumatoid?arthritis 1990-2017: a systematic analysis of the?Global Burden of Disease study 2017. Ann?Rheum Dis. 2019;78(11):1463-71. 

  6. Vande Walle L, Van Opdenbosch N, Jacques P,?Fossoul A, Verheugen E, Vogel P, et al.?Negative regulation of the NLRP3?inflammasome by A20 protects against arthritis.?Nature. 2014;512(7512):69-73. 

  7. 정순현, 조종관, 김소연, 김영일. 계작지모가우슬탕(桂芍知母加牛膝湯) 약침이?류마티스 관절염 생쥐에 미치는 영향. 한의학연구소 논문집. 2016;24(2):35-57. 

  8. 오승준, 하현주, 구지향, 박양춘, 오민석, 정인철, et al. 한약의 류마티스 관절염 동물 모델에 대한?치료효과: 국내 및 국외 논문에 대한 체계적?문헌 고찰. 한방재활의학과학회지. 2020;30(3):103-16. 

  9. Firestein GS. Evolving concepts of rheumatoid?arthritis. Nature. 2003;423(6937):356-61. 

  10. Jiang Q, Yang G, Xiao F, Xie J, Wang S, Lu?L, et al. Role of Th22 Cells in the?Pathogenesis of Autoimmune Diseases. Front?Immunol. 2021;12:688066. 

  11. Jiang Q, Yang G, Liu Q, Wang S, Cui D.?Function and Role of Regulatory T Cells in?Rheumatoid Arthritis. Front Immunol.?2021;12:626193. 

  12. Muruve DA, Petrilli V, Zaiss AK, White LR,?Clark SA, Ross PJ, et al. The inflammasome?recognizes cytosolic microbial and host DNA?and triggers an innate immune response.?Nature. 2008;452(7183):103-7. 

  13. Fransen J, Creemers MC, Van Riel PL.?Remission in rheumatoid arthritis: agreement of?the disease activity score (DAS28) with the?ARA preliminary remission criteria.?Rheumatology (Oxford). 2004;43(10):1252-5. 

  14. Sui J, Li H, Fang Y, Liu Y, Li M, Zhong B,?et al. NLRP1 gene polymorphism influences?gene transcription and is a risk factor for?rheumatoid arthritis in han chinese. Arthritis?Rheum. 2012;64(3):647-54. 

  15. Pontillo A, Brandao L, Guimaraes R, Segat L,?Araujo J, Crovella S. Two SNPs in NLRP3?gene are involved in the predisposition to?type-1 diabetes and celiac disease in a?pediatric population from northeast Brazil.?Autoimmunity. 2010;43(8):583-9. 

  16. Bank S, Julsgaard M, Abed OK, Burisch J,?Broder Brodersen J, Pedersen NK, et al.?Polymorphisms in the NFkB, TNF-alpha,?IL-1beta, and IL-18 pathways are associated?with response to anti-TNF therapy in Danish?patients with inflammatory bowel disease.?Aliment Pharmacol Ther. 2019;49(7):890-903. 

  17. Zhang QB, Qing YF, He YL, Xie WG, Zhou?JG. Association of NLRP3 polymorphisms with?susceptibility to primary gouty arthritis in a?Chinese Han population. Clin Rheumatol.?2018;37(1):235-44. 

  18. Gil ME, Coetzer TL. Real-time quantitative?PCR of telomere length. Mol Biotechnol.?2004;27(2):169-72. 

  19. Komatsu N, Takayanagi H. Mechanisms of?joint destruction in rheumatoid arthritis - immune cell-fibroblast-bone interactions. Nat?Rev Rheumatol. 2022;18(7):415-29. 

  20. Pap T, Korb-Pap A. Cartilage damage in?osteoarthritis and rheumatoid arthritis--two?unequal siblings. Nat Rev Rheumatol.?2015;11(10):606-15. 

  21. Araki Y, Mimura T. Matrix Metalloproteinase?Gene Activation Resulting from Disordred?Epigenetic Mechanisms in Rheumatoid?Arthritis. Int J Mol Sci. 2017;18(5). 

  22. Lamkanfi M, Dixit VM. Mechanisms and functions of inflammasomes. Cell.?2014;157(5):1013-22. 

  23. Broz P, Dixit VM. Inflammasomes: mechanism?of assembly, regulation and signalling. Nature?Reviews Immunology. 2016;16(7):407-20. 

  24. Yang J, Zhao Y, Shao F. Non-canonical?activation of inflammatory caspases by?cytosolic LPS in innate immunity. Curr Opin?Immunol. 2015;32:78-83. 

  25. Lee MS. Role of innate immunity in diabetes?and metabolism: recent progress in the study?of inflammasomes. Immune Netw.?2011;11(2):95-9. 

  26. Takayanagi H. Osteoimmunology: shared?mechanisms and crosstalk between the immune?and bone systems. Nat Rev Immunol.?2007;7(4):292-304. 

  27. Shim JH, Stavre Z, Gravallese EM. Bone Loss?in Rheumatoid Arthritis: Basic Mechanisms and?Clinical Implications. Calcif Tissue Int.?2018;102(5):533-46. 

  28. Okamoto K, Nakashima T, Shinohara M,?Negishi-Koga T, Komatsu N, Terashima A, et?al. Osteoimmunology: The Conceptual?Framework Unifying the Immune and Skeletal?Systems. Physiol Rev. 2017;97(4):1295-349. 

  29. Alippe Y, Mbalaviele G. Omnipresence of?inflammasome activities in inflammatory bone?diseases. Semin Immunopathol.?2019;41(5):607-18. 

  30. Bauernfeind FG, Horvath G, Stutz A, Alnemri?ES, MacDonald K, Speert D, et al. Cutting?edge: NF-kappaB activating pattern recognition?and cytokine receptors license NLRP3?inflammasome activation by regulating NLRP3?expression. J Immunol. 2009;183(2):787-91. 

  31. Dieguez-Gonzalez R, Calaza M, Perez-Pampin?E, Balsa A, Blanco FJ, Canete JD, et al.?Analysis of TNFAIP3, a feedback inhibitor of?nuclear factor-kappaB and the neighbor?intergenic 6q23 region in rheumatoid arthritis?susceptibility. Arthritis Res Ther.?2009;11(2):R42. 

  32. Haneklaus M, O'Neill LA, Coll RC.?Modulatory mechanisms controlling the NLRP3?inflammasome in inflammation: recent?developments. Curr Opin Immunol.?2013;25(1):40-5. 

  33. Bauernfeind F, Rieger A, Schildberg FA,?Knolle PA, Schmid-Burgk JL, Hornung V.?NLRP3 inflammasome activity is negatively?controlled by miR-223. J Immunol.?2012;189(8):4175-81. 

  34. Zhong Z, Sanchez-Lopez E, Karin M.?Autophagy, NLRP3 inflammasome and?auto-inflammatory/immune diseases. Clin Exp?Rheumatol. 2016;34(4 Suppl 98):12-6. 

  35. Kastbom A, Verma D, Eriksson P, Skogh T,?Wingren G, Soderkvist P. Genetic variation in?proteins of the cryopyrin inflammasome?influences susceptibility and severity of?rheumatoid arthritis (the Swedish TIRA?project). Rheumatology (Oxford).?2008;47(4):415-7. 

  36. Tourkochristou E, Aggeletopoulou I,?Konstantakis C, Triantos C. Role of NLRP3?inflammasome in inflammatory bowel diseases.?World J Gastroenterol. 2019;25(33):4796-804. 

  37. Dinarello CA. A clinical perspective of IL-1β?as the gatekeeper of inflammation. Eur J?Immunol. 2011;41(5):1203-17. 

  38. van de Veerdonk FL, Netea MG. New Insights?in the Immunobiology of IL-1 Family?Members. Front Immunol. 2013;4:167. 

  39. Kanneganti TD, Lamkanfi M, Nunez G.?Intracellular NOD-like receptors in host defense?and disease. Immunity. 2007;27(4):549-59. 

  40. Palomo J, Dietrich D, Martin P, Palmer G,?Gabay C. The interleukin (IL)-1 cytokine?family--Balance between agonists and antagonists in inflammatory diseases. Cytokine.?2015;76(1):25-37. 

  41. He Y, Hara H, Nunez G. Mechanism and?Regulation of NLRP3 Inflammasome?Activation. Trends Biochem Sci.?2016;41(12):1012-21. 

  42. Addobbati C, da Cruz HLA, Adelino JE, Melo?Tavares Ramos AL, Fragoso TS, Domingues?A, et al. Polymorphisms and expression of?inflammasome genes are associated with the?development and severity of rheumatoid?arthritis in Brazilian patients. Inflamm Res.?2018;67(3):255-64. 

  43. Mathews RJ, Robinson JI, Battellino M, Wong?C, Taylor JC, Eyre S, et al. Evidence of?NLRP3-inflammasome activation in rheumatoid?arthritis (RA); genetic variants within the?NLRP3-inflammasome complex in relation to?susceptibility to RA and response to anti-TNF?treatment. Ann Rheum Dis.?2014;73(6):1202-10. 

  44. Choulaki C, Papadaki G, Repa A, Kampouraki?E, Kambas K, Ritis K, et al. Enhanced activity?of NLRP3 inflammasome in peripheral blood?cells of patients with active rheumatoid?arthritis. Arthritis Res Ther. 2015;17(1):257. 

  45. Kim HW, Kwon YJ, Park BW, Song JJ, Park?YB, Park MC. Differential expressions of?NOD-like receptors and their associations with?inflammatory responses in rheumatoid arthritis.?Clin Exp Rheumatol. 2017;35(4):630-7. 

  46. Ruscitti P, Cipriani P, Di Benedetto P,?Liakouli V, Berardicurti O, Carubbi F, et al.?Monocytes from patients with rheumatoid?arthritis and type 2 diabetes mellitus display?an increased production of interleukin (IL)-1β?via the nucleotide-binding domain and?leucine-rich repeat containing family pyrin?3(NLRP3)-inflammasome activation: a possible?implication for therapeutic decision in these?patients. Clin Exp Immunol. 2015;182(1):35-44. 

관련 콘텐츠

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로